Objective

This retrospective analysis compares incidence of hypoglycemia with and without use of the specialized EndoTool EREI (estimated residual extracellular insulin) adjustment feature.

Setting

Cohort of 84 community hospitals.

Results

• Incidence of hypoglycemia <40 mg/dL was 63% lower when the EndoTool EREI adjustment feature was enabled.
• Specifically, hypoglycemia occurred at a rate of one for every 351 patient days of intravenous insulin therapy with the EREI adjustment feature versus one for every 129 patient days without the EREI adjustment feature.

Conclusions

Use of the specialized EndoTool EREI adjustment feature significantly reduces incidence of hypoglycemia without significantly impacting glycemic control.